Back to Results
First PageMeta Content
Health / Meningococcal vaccine / Meningococcal disease / Neisseria / Center for Biologics Evaluation and Research / Meningitis / FluMist / NmVac4-A/C/Y/W-135 / JN-International Medical Corporation / Vaccines / Medicine / Vaccination


FDA Media Call on Trumenba Approval for Serogroup B Meningococcal Disease Moderator: Jennifer Rodriguez October 29, 2014 3:30 pm EDT Coordinator:
Add to Reading List

Open Document

File Size: 30,31 KB

Share Result on Facebook

Company

CBS News / The Washington Post / Serogroup / National Public Radio / /

Continent

Europe / /

Country

United States / Australia / /

Event

FDA Phase / /

IndustryTerm

media briefing / important medical products / pharmaceutical / /

MedicalCondition

both meningitis / invasive meningococcal disease / disease / B meningococcal disease / meningococcal sepsis / meningococcal disease / B disease / infection / hemophilus influenza B / meningitis / /

MedicalTreatment

immunization / antibiotics / /

Organization

Food and Drug Administration / FDA’s office of Media Affairs / FDA Center for Biologics Evaluation and Research / FDA / Center of Disease Control Prevention / Center for Biologics Evaluation and Research at FDA / /

Person

Richard Harris / B. Tom Burton / Tom Burton / Julie Zosmar / Jennifer Rodriguez / Karen Midthun / Sue Sutter / Leanne Winnick / Lynn Peterson / /

Position

pm EDT Coordinator / Coordinator / director / /

Product

one vaccine / /

PublishedMedium

The Wall Street Journal / The Washington Post / /

SocialTag